Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment G Bertolini, L Roz, P Perego, M Tortoreto, E Fontanella, L Gatti, G Pratesi, ... Proceedings of the National Academy of Sciences 106 (38), 16281-16286, 2009 | 1010 | 2009 |
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer M Boeri, C Verri, D Conte, L Roz, P Modena, F Facchinetti, E Calabrò, ... Proceedings of the National Academy of Sciences 108 (9), 3713-3718, 2011 | 843 | 2011 |
The FHIT gene at 3p14. 2 is abnormal in lung cancer G Sozzi, ML Veronese, M Negrini, R Baffa, MG Cotticelli, H Inoue, ... Cell 85 (1), 17-26, 1996 | 787 | 1996 |
Quantification of free circulating DNA as a diagnostic marker in lung cancer G Sozzi, D Conte, ME Leon, R Cirincione, L Roz, C Ratcliffe, E Roz, ... Journal of clinical oncology 21 (21), 3902-3908, 2003 | 736 | 2003 |
Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell … MP Simon, F Pedeutour, N Sirvent, J Grosgeorge, F Minoletti, JM Coindre, ... Nature genetics 15 (1), 95-98, 1997 | 603 | 1997 |
Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients G Sozzi, D Conte, L Mariani, S Lo Vullo, L Roz, C Lombardo, MA Pierotti, ... Cancer research 61 (12), 4675-4678, 2001 | 571 | 2001 |
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy U Pastorino, M Silva, S Sestini, F Sabia, M Boeri, A Cantarutti, ... Annals of Oncology 30 (7), 1162-1169, 2019 | 549 | 2019 |
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial U Pastorino, M Rossi, V Rosato, A Marchiano, N Sverzellati, C Morosi, ... European Journal of Cancer Prevention 21 (3), 308-315, 2012 | 521 | 2012 |
Replacement of Fhit in cancer cells suppresses tumorigenicity Z Siprashvili, G Sozzi, LD Barnes, P McCue, AK Robinson, V Eryomin, ... Proceedings of the National Academy of Sciences 94 (25), 13771-13776, 1997 | 491 | 1997 |
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study G Sozzi, M Boeri, M Rossi, C Verri, P Suatoni, F Bravi, L Roz, D Conte, ... Journal of clinical oncology 32 (8), 768-773, 2014 | 470 | 2014 |
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. F Pezzella, U Pastorino, E Tagliabue, S Andreola, G Sozzi, G Gasparini, ... The American journal of pathology 151 (5), 1417, 1997 | 444 | 1997 |
Biomarkers in lung cancer screening: achievements, promises, and challenges LM Seijo, N Peled, D Ajona, M Boeri, JK Field, G Sozzi, R Pio, JJ Zulueta, ... Journal of Thoracic Oncology 14 (3), 343-357, 2019 | 443 | 2019 |
Loss of FHIT Function in Lung Cancer and Preinvasive Bronchial Lesions G Sozzi, U Pastorino, L Moiraghi, E Tagliabue, F Pezzella, C Ghirelli, ... Cancer research 58 (22), 5032-5037, 1998 | 421 | 1998 |
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues MP Martelli, G Sozzi, L Hernandez, V Pettirossi, A Navarro, D Conte, ... The American journal of pathology 174 (2), 661-670, 2009 | 413 | 2009 |
Immunocytochemical markers in stage I lung cancer: relevance to prognosis. U Pastorino, S Andreola, E Tagliabue, F Pezzella, M Incarbone, G Sozzi, ... Journal of clinical oncology 15 (8), 2858-2865, 1997 | 406 | 1997 |
Antibody–Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non–small cell lung cancer subsequent to PD-1/PD-L1 blockade G Lo Russo, M Moro, M Sommariva, V Cancila, M Boeri, G Centonze, ... Clinical Cancer Research 25 (3), 989-999, 2019 | 401 | 2019 |
The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control L Sard, P Accornero, S Tornielli, D Delia, G Bunone, M Campiglio, ... Proceedings of the National Academy of Sciences 96 (15), 8489-8492, 1999 | 371 | 1999 |
Deletions of 17p and p53 Mutations in Preneoplastic Lesions of the Lung G Sozzi, M Miozzo, R Donghi, S Pilotti, CT Cariani, U Pastorino, ... Cancer research 52 (21), 6079-6082, 1992 | 365 | 1992 |
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas P Modena, E Lualdi, F Facchinetti, L Galli, MR Teixeira, S Pilotti, G Sozzi Cancer research 65 (10), 4012-4019, 2005 | 351 | 2005 |
Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms GA Calin, MG Di Iasio, E Caprini, I Vorechovsky, PG Natali, G Sozzi, ... Oncogene 19 (9), 1191-1195, 2000 | 346 | 2000 |